Resmed agrees $490m MatrixCare sale to Frazier Healthcare Partners
ResMed Inc. has agreed to sell its MatrixCare healthcare software business to Frazier Healthcare Partners for $490 million in cash, reversing part of a diversification strategy that began when the medical-device company acquired MatrixCare for $750 million in 2018. The transaction is expected to close during the first quarter of Resmed’s fiscal year 2027, subject